The potential pathophysiological role of tissue factor in age-related macular degeneration

References

• Friedman DS, O’Colmain BJ, Munoz B et al. Prevalence of age-related macular degeneration in the United States. Arch. Ophthalmol.122, 564–572 (2004).
   PubMed Web of Science ®Google Scholar
• Age-Related Eye Disease Study Research Group. Risk factors associated with age-related macular degeneration. A case–control study in the age-related eye disease study: age-related eye disease study report number 3. Ophthalmology107, 2224–2232 (2000).
   PubMed Web of Science ®Google Scholar
• Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, β carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch. Ophthalmol.119, 1417–1436 (2001).
   PubMed Web of Science ®Google Scholar
• Clemons TE, Milton RC, Klein R, Seddon JM, Ferris FL 3rd. Risk factors for the incidence of advanced age-related macular degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19. Ophthalmology112, 533–539 (2005).
   PubMed Web of Science ®Google Scholar
• Evans JR, Fletcher AE, Wormald RP. 28,000 cases of age related macular degeneration causing visual loss in people aged 75 years and above in the United Kingdom may be attributable to smoking. Br. J. Ophthalmol.89, 550–553 (2005).
   PubMed Web of Science ®Google Scholar
• Hyman L, Neborsky R. Risk factors for age-related macular degeneration: an update. Curr. Opin. Ophthalmol.13, 171–175 (2002).
   PubMedGoogle Scholar
• Tuo J, Bojanowski CM, Chan CC. Genetic factors of age-related macular degeneration. Prog. Retin. Eye Res.23, 229–249 (2004).
   PubMed Web of Science ®Google Scholar
• Hughes AE, Orr N, Patterson C et al. Neovascular age-related macular degeneration risk based on CFH, LOC387715/HTRA1, and smoking. PLoS Med.4, e355 (2007).
   Google Scholar
• Francis PJ, Schultz DW, Hamon S, Ott J, Weleber RG, Klein ML. Haplotypes in the complement factor H (CFH) gene: associations with drusen and advanced age-related macular degeneration. PLoS ONE2, e1197 (2007).
   PubMed Web of Science ®Google Scholar
• Klein R. Overview of progress in the epidemiology of age-related macular degeneration. Ophthalmic Epidemiol.14, 184–187 (2007).
   PubMed Web of Science ®Google Scholar
• Ding X, Patel M, Chan CC. Molecular pathology of age-related macular degeneration. Prog. Retin. Eye Res.28, 1–18 (2009).
   PubMed Web of Science ®Google Scholar
• Anderson DH, Talaga KC, Rivest AJ et al. Characterization of β amyloid assemblies in drusen: the deposits associated with aging and age-related macular degeneration. Exp. Eye Res.78, 243–256 (2004).
   PubMed Web of Science ®Google Scholar
• Crabb JW, Miyagi M, Gu X et al. Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc. Natl Acad. Sci. USA99, 14682–14687 (2002).
   PubMed Web of Science ®Google Scholar
• Johnson LV, Leitner WP, Staples MK, Anderson DH. Complement activation and inflammatory processes in drusen formation and age related macular degeneration. Exp. Eye Res.73, 887–896 (2001).
   PubMed Web of Science ®Google Scholar
• Mullins RF, Russell SR, Anderson DH, Hageman GS. Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J.14, 835–846 (2000).
   PubMed Web of Science ®Google Scholar
• de Jong PT. Age-related macular degeneration. N. Engl. J. Med.355, 1474–1485 (2006).
   PubMed Web of Science ®Google Scholar
• Coleman HR, Chan CC, Ferris FL III, Chew EY. Age-related macular degeneration. Lancet372, 1835–1845 (2008).
   PubMed Web of Science ®Google Scholar
• Chu AJ. Role of tissue factor in thrombosis. Coagulation–inflammation–thrombosis circuit. Front. Biosci.11, 256–271 (2006).
   PubMed Web of Science ®Google Scholar
• Mackman N. Role of tissue factor in hemostasis, thrombosis, and vascular development. Arterioscler. Thromb. Vasc. Biol.24, 1015–1022 (2004).
   PubMed Web of Science ®Google Scholar
• Drake TA, Morrissey JH, Edgington TS. Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am. J. Pathol.134, 1087–1097 (1989).
   PubMed Web of Science ®Google Scholar
• Edwards RL, Rickles FR, Bobrove AM. Mononuclear cell tissue factor: cell of origin and requirements for activation. Blood54, 359–370 (1979).
   PubMed Web of Science ®Google Scholar
• Bluff JE, Brown NJ, Reed MW, Staton CA. Tissue factor, angiogenesis and tumour progression. Breast. Cancer Res.10, 204 (2008).
   PubMed Web of Science ®Google Scholar
• Mackman N, Sawdey MS, Keeton MR, Loskutoff DJ. Murine tissue factor gene expression in vivo. Tissue and cell specificity and regulation by lipopolysaccharide. Am. J. Pathol.143, 76–84 (1993).
   PubMedGoogle Scholar
• Muller I, Klocke A, Alex M et al. Intravascular tissue factor initiates coagulation via circulating microvesicles and platelets. FASEB J.17, 476–478 (2003).
   PubMed Web of Science ®Google Scholar
• Butenas S, Bouchard BA, Brummel-Ziedins KE, Parhami-Seren B, Mann KG. Tissue factor activity in whole blood. Blood105, 2754–2770 (2005).
   Google Scholar
• Engelmann B. Initiation of coagulation by tissue factor carriers in blood. Blood Cells Mol. Dis.36, 188–190 (2006).
   PubMedGoogle Scholar
• Chu AJ. Tissue factor mediates inflammation. Arch. Biochem. Biophys.440, 123–132 (2005).
   PubMed Web of Science ®Google Scholar
• Pendurthi UR, Ghosh S, Mandal SK, Rao LVM. Tissue factor activation: is disulfide bond switching a regulatory mechanism? Blood110, 3900–3908 (2007).
   PubMedGoogle Scholar
• Ahamed J, Versteeg HH, Kerver M et al. Disulfide isomerization switches tissue factor from coagulation to cell signaling. Proc. Natl Acad. Sci. USA103, 13932–13937 (2006).
   PubMed Web of Science ®Google Scholar
• Chen J, Bierhaus A, Schiekofer S et al. Tissue factor – a receptor involved in the control of cellular properties, including angiogenesis. Thromb. Haemost.86, 334–345 (2001).
   PubMed Web of Science ®Google Scholar
• Abe K, Shoji M, Chen J et al. Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor. Proc. Natl Acad. Sci. USA96, 8663–8668 (1999).
   PubMed Web of Science ®Google Scholar
• Zhang Y, Deng Y, Luther T et al. Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice. J. Clin. Invest.94, 1320–1327 (1994).
   PubMed Web of Science ®Google Scholar
• Belting M, Dorrell MI, Sandgren S et al. Regulation of angiogenesis by tissue factor cytoplasmic domain signaling. Nat. Med.10, 502–509 (2004).
   PubMed Web of Science ®Google Scholar
• Ahamed J, Ruf W. Protease-activated receptor 2-dependent phosphorylation of the tissue factor cytoplasmic domain. J. Biol. Chem.279, 23038–23044 (2004).
   PubMed Web of Science ®Google Scholar
• Mohle R, Green D, Moore MA, Nachman RL, Rafii S. Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc. Natl Acad. Sci. USA94, 663–668 (1997).
   PubMed Web of Science ®Google Scholar
• Chiarugi V, Ruggiero M, Magnelli L. Molecular polarity in endothelial cells and tumor-induced angiogenesis. Oncol. Res.12, 1–4 (2000).
   PubMedGoogle Scholar
• Chu AJ. Tissue factor upregulation drives a thrombosis-inflammation circuit in relation to cardiovascular complications. Cell Biochem. Funct.24, 173–192 (2006).
   PubMedGoogle Scholar
• Riewald M, Ruf W. Mechanistic coupling of protease signaling and initiation of coagulation by tissue factor. Proc. Natl Acad. Sci. USA98, 7742–7747 (2001).
   PubMed Web of Science ®Google Scholar
• Schoenmakers SH, Reitsma PH, Spek CA. Blood coagulation factors as inflammatory mediators. Blood Cells Mol. Dis.34, 30–37 (2005).
   PubMed Web of Science ®Google Scholar
• Drake WT, Lopes NN, Fenton JW, Issekutz AC. Thrombin enhancement of interleukin-1 and tumor necrosis factor-α induced polymorphonuclear leukocyte migration. Lab. Invest.67, 617–627 (1992).
   PubMed Web of Science ®Google Scholar
• Sower LE, Froelich CJ, Carney DH, Fenton JW, Klimpel GR. Thrombin induces IL-6 production in fibroblasts and epithelial cells. Evidence for the involvement of the seven-transmembrane domain (STD) receptor for α-thrombin. J. Immunol.155, 895–901 (1995).
   PubMed Web of Science ®Google Scholar
• Szaba FM, Smiley ST. Roles for thrombin and fibrin(ogen) in cytokine/chemokine production and macrophage adhesion in vivo. Blood99, 1053–1059 (2002).
   PubMed Web of Science ®Google Scholar
• Contrino J, Goralnick S, Qi J, Hair G, Rickles FR, Kreutzer DL. Fibrin induction of tissue factor in human vascular endothelial cells. Circ.96, 605–613 (1997).
   PubMedGoogle Scholar
• Sorensen BB, Rao LV, Tornehave D, Gammeltoft S, Petersen LC. Antiapoptotic effect of coagulation Factor VIIa. Blood102, 1708–1715 (2003).
   PubMed Web of Science ®Google Scholar
• Jiang X, Guo YL, Bromberg ME. Formation of tissue factor–Factor VIIa–Factor Xa complex prevents apoptosis in human breast cancer cells. Thromb. Haemost.96, 196–201 (2006).
   PubMedGoogle Scholar
• Versteeg HH, Spek CA, Slofstra SH, Diks SH, Richel DJ, Peppelenbosch MP. FVIIa:TF induces cell survival via G12/G13-dependent Jak/STAT activation and BclXL production. Circ. Res.94, 1032–1040 (2004).
   PubMed Web of Science ®Google Scholar
• Cohen LH, Noell WK. Relationships between visual function and metabolism. In: Biochemistry of the Retina. Graymore CN (Ed.). Academic Press, NY, USA, 36–49 (1965).
   Google Scholar
• Young RW, Bok D. Participation of the retinal pigment epithelium in the rod outer segment renewal process. J. Cell. Biol.42, 392–403 (1969).
   PubMed Web of Science ®Google Scholar
• Wilson TM, Strang R, Wallace J, Horton PW, Johnson NF. The measurement of the choroidal blood flow in the rabbit using 85-krypton. Exp. Eye Res.16(6), 421–425 (1973).
   PubMedGoogle Scholar
• Metelitsina TI, Grunwald JE, DuPont JC, Ying GS, Brucker AJ, Dunaief JL. Foveolar choroidal circulation and choroidal neovascularization in age-related macular degeneration. Invest. Ophthalmol. Vis. Sci.49(1), 358–363 (2008).
   PubMed Web of Science ®Google Scholar
• Arjamaa O, Nikinmaa M, Salminen A, Kaarniranta K. Regulatory role of HIF-1α in the pathogenesis of age-related macular degeneration (AMD). Ageing Res. Rev.8(4), 349–358 (2009).
   PubMed Web of Science ®Google Scholar
• Curtis TM, Gardiner TA, Stitt AW. Microvascular lesions of diabetic retinopathy: clues towards understanding pathogenesis? Eye23(7), 1496–1508 (2009).
   PubMed Web of Science ®Google Scholar
• Sakamoto T, Ito S, Yoshikawa H et al. Tissue factor increases in the aqueous humor of proliferative diabetic retinopathy. Graefes. Arch. Clin. Exp. Ophthalmol.239(11), 865–871 (2001).
   PubMedGoogle Scholar
• Topouzis F, Anastasopoulos E, Augood C et al. Association of diabetes with age-related macular degeneration in the EUREYE study. Br. J. Ophthalmol.93(8), 1037–1041 (2009).
   PubMed Web of Science ®Google Scholar
• Strukova S. Blood coagulation-dependent inflammation. Coagulation-dependent inflammation and inflammation-dependent thrombosis. Front. Biosci.11, 59–80 (2006).
   PubMed Web of Science ®Google Scholar
• Grossniklaus HE, Ling JX, Wallace TM et al. Macrophage and retinal pigment epithelium expression of angiogenic cytokines in choroidal neovascularization. Mol. Vis.8, 119–126 (2002).
   PubMed Web of Science ®Google Scholar
• Contrino J, Hair G, Reutzer DL, Rickles F. In situ detection of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast disease. Nat. Med.2, 209–215 (1996).
   PubMed Web of Science ®Google Scholar
• Bora PS, Hu Z, Tezel TH et al. Immunotherapy for choroidal neovascularization in a laser-induced mouse model simulating exudative (wet) macular degeneration. Proc. Natl Acad. Sci. USA100, 2679–2684 (2003).
   PubMed Web of Science ®Google Scholar
• Tezel TH, Bodek E, Sonmez K et al. Targeting tissue factor for immunotherapy of choroidal neovascularization by intravitreal delivery of Factor VII-Fc chimeric antibody. Ocul. Immunol. Inflamm.15, 3–10 (2007).
   PubMed Web of Science ®Google Scholar
• Redecha P, Tilley R, Tencati M et al. Tissue factor: a link between C5a and neutrophil activation in antiphospholipid antibody induced fetal injury. Blood110, 2423–2431 (2007).
   PubMed Web of Science ®Google Scholar
• Cunningham MA, Romas P, Hutchinson P, Holdsworth SR, Tipping PG. Tissue factor and Factor VIIa receptor/ligand interactions induce proinflammatory effects in macrophages. Blood94, 3413–3420 (1999).
   PubMed Web of Science ®Google Scholar
• Sivaprasad S, Bailey TA, Chong VN. Bruch’s membrane and the vascular intima: is there a common basis for age-related changes and disease? Clin. Experiment. Ophthalmol.33, 518–523 (2005).
   PubMedGoogle Scholar
• Patel M, Chan CC. Immunopathological aspects of age-related macular degeneration. Semin. Immunopathol.30, 97–110 (2008).
   PubMed Web of Science ®Google Scholar